Leukamenin F exhibits significant potential in pharmaceutical research due to its notable anti-inflammatory and neuroprotective activities. It has been investigated for its ability to modulate cellular pathways involved in oxidative stress and neuronal damage, making it a candidate of interest in the development of treatments for neurodegenerative conditions such as Alzheimer’s and Parkinson’s diseases. Additionally, Leukamenin F demonstrates cytotoxic effects against certain cancer cell lines, suggesting possible application in oncology for targeting tumor growth. Its natural origin and bioactive profile support further exploration as a lead compound in drug discovery, particularly in designing derivatives with enhanced potency and selectivity.